Targeting RB1 Loss in Cancers

SIMPLE SUMMARY: Irreversible defects in RB1 tumor suppressor functions often predict poor outcomes in cancer patients. However, the RB1-defecient status can be a benefit as well for them, as it generates a variety of vulnerabilities induced through the upregulation of RB1 targets, relief from functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Linn, Paing, Kohno, Susumu, Sheng, Jindan, Kulathunga, Nilakshi, Yu, Hai, Zhang, Zhiheng, Voon, Dominic, Watanabe, Yoshihiro, Takahashi, Chiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345210/
https://www.ncbi.nlm.nih.gov/pubmed/34359636
http://dx.doi.org/10.3390/cancers13153737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345210/
https://www.ncbi.nlm.nih.gov/pubmed/34359636
http://dx.doi.org/10.3390/cancers13153737

Ejemplares similares